Market Analysis and Insights: Global Hyaluronic Acid-based Biomaterials Market

Hyaluronic acid-based biomaterials, is a carbohydrate, more specifically a mucopolysaccharide occurring naturally throughout the human body. It is found in the highest concentrations in fluids in the eyes and joints. It has been used in a wide range of orthopedic injections, ophthalmic solutions, viscoelastic injections for ophthalmic surgery, cosmetic fillers, surgical anti-adhesion products, skin care products and food supplements.

Common commercially available hyaluronic acid-based biomaterials are mainly hyaluronic acid. Hyaluronic acid (HA) is known as hyaluronan or hyaluronate. In this report, the volume of hyaluronic acid-based biomaterials is calculated by pure hyaluronic acid powder.

Due to the COVID-19 pandemic, the global Hyaluronic Acid-based Biomaterials market size is estimated to be worth US$ 216.8 million in 2022 and is forecast to a readjusted size of US$ 267.3 million by 2029 with a CAGR of 3.0% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, Cosmetic Grade accounting for % of the Hyaluronic Acid-based Biomaterials global market in 2022, is projected to value US$ million by 2029, growing at a revised % CAGR from 2023 to 2029. While Medical Hygiene segment is altered to an % CAGR throughout this forecast period.

The major manufacturers of Hyaluronic Acid-based Biomaterials are concentrated in Bloomage BioTechnology, Shandong Galaxy Bio-Tech, Kewpie, CPN, China Eastar and FocusChem Biotech. Bloomage BioTechnology is the world leader, holding 42% production market share.

In the consumption market, China is the largest consumption market. The consumption share of China is 27%.

Global Hyaluronic Acid-based Biomaterials Scope and Market Size

The global Hyaluronic Acid-based Biomaterials market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Hyaluronic Acid-based Biomaterials market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2029.


Segment by Type


Cosmetic Grade

Food Grade

Pharmaceutical Grade


Segment by Application


Medical Hygiene

Plastic Surgery

Health Products

Cosmetic

By Region

United States

Europe

China

Japan

Southeast Asia

India

Other Regions


By Company


Kewpie

CPN

Shiseido

Novozymes

Bloomage BioTechnology

Shandong Galaxy Bio-Tech

China Eastar

FocusChem Biotech

Shandong Topscience Biotech

QuFu GuangLong Biochem

Weifang Lide Bioengineering

Jiangsu Haihua Biotech

Qufu Liyang Biochem Industrial

Tongxiang Hengji biotechnology